Purchase Order HT001415P3481

<p>This federal contract award with ID HT001416P0324 was issued by the Defense Health Agency, a defense agency, to Lifecell Corporation, a for-profit manufacturer, for $93,587.00 on a firm fixed price purchase order. The award does not have a set-aside designation. The contract is for an item described as 2040002 20X40 SP100208-010, with a completion date of December 29, 2015. No further details about the specific products or services being provided are included in the information given.</p>

<p>This is a federal contract award from the Defense Health Agency, a defense agency, to Lifecell Corporation, a for-profit manufacturer. The contract, worth $121,473.00, is for the delivery of STRATTICE 20X30 products. The contract is a firm fixed price purchase order with a completion date of July 14, 2015. The contract does not have a set-aside designation.</p>

This firm fixed-price purchase order for $5,283 was awarded by the Defense Health Agency (DHA) to Lifecell Corporation, a division of Allergan, Inc. The contract is for the delivery of 102020 3X7 ALLODERM .52-1.02 products, with a final completion date of September 4, 2015. This contract does not have a set-aside designation. Lifecell Corporation is a for-profit manufacturer of goods, and this award represents their most recent federal contract with the DHA, with their previous federal...

This federal contract award, identified as HT001416A0071|0002, was issued by the Defense Health Agency (DHA) to Lifecell Corporation, a division of Allergan, Inc. The contract has a ceiling value of $150,000.00 and is for the procurement of INSTRUMENTS/IMPLANTS. The contract type is a BPA Call with a Firm Fixed Price pricing arrangement. The period of performance extends through September 30, 2016. This award does not utilize a set-aside. As a manufacturer of goods, Lifecell Corporation is the...

<p>This is a $150,000.00 Firm Fixed Price Blanket Purchase Agreement (BPA) call contract awarded by the Defense Health Agency (DHA), a defense agency, to Lifecell Corporation, a division of Allergan, Inc. The contract is for the delivery of medical implants/medical instruments. The award has no set-aside designation. The contract has an ultimate completion date of September 30, 2017.</p>

This federal contract award was issued by the Bureau of Medicine and Surgery, a Defense agency, to Lifecell Corporation, a for-profit manufacturer of goods. The $118,040.00 firm fixed-price purchase order is for the drop shipment of Alloderm Perforated 9.6x19.3 and has an ultimate completion date of October 2, 2017. The contract was awarded on November 3, 2016 and was not set aside for any specific designation. The Bureau of Medicine and Surgery is responsible for the medical and dental care...

This is a federal contract award from the Medical Command (MEDCOM) division of the U.S. Department of Defense to Lifecell Corporation, a for-profit manufacturer of goods. The contract, valued at $87,835.00, is for the provision of various allograft bone and tissue products. The contract is a Blanket Purchase Agreement (BPA) call order with a firm fixed price pricing type, and has an ultimate completion date of September 30, 2016. The place of performance is Somerville, New Jersey. This...

<p>The Defense Health Agency awarded a Firm Fixed Price BPA Call contract to Lifecell Corporation, a division of Allergan, Inc., to provide medical instruments and equipment. The contract has a potential value of $700,000.00 and a completion date of March 15, 2018. The contract does not have a set-aside designation. The contract was awarded on February 28, 2018 for the provision of medical instruments and equipment to be delivered in Bethesda, MD 20889, USA.</p>

This federal contract award is for the purchase of ALLODERM (RTU) CONTOUR MEDIUM, IMPLANT by the Bureau of Medicine and Surgery, a Defense agency. The $106,236.00 firm fixed price purchase order was awarded to Lifecell Corporation, a for-profit manufacturer, on September 8, 2016. The contract has a period of performance through September 30, 2016 and does not utilize a set-aside designation. The contract was awarded by the Bureau of Medicine and Surgery, which is a component of the U.S. Navy.

<p>This is a firm fixed-price purchase order contract awarded by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Lifecell Corporation, a division of Allergan, Inc. The contract is for the supply of ALLODERM SELECT REGENERATIVE, SURGICAL IMPLANT, identified by the contract number N0018317P0458. The contract has a ceiling value of $57,268.00 and an ultimate completion date of March 3, 2017. This contract does not have a set-aside designation.</p>